ChemicalBook
bioleaper 企業の連絡先情報
名前:
bioleaper
電話番号:
-
電子メール:
guojing@bioleaper.com
国籍:
China
ウェブサイト:
www.bioleaper.com/
商品の合計数:
5615
47
48
49
50
51
52
53
54
55
56
57
製品カタログ
Anti-LINGO1 Reference Antibody (opicinumab)
Anti-LY75 / CD205 Reference Antibody (CDX-1401)
Anti-Mesothelin Reference Antibody (NIH patent anti-Mesothelin)
Anti-MMP9 Reference Antibody (Yeda patent anti-MMP-9)
Anti-MUC5AC Reference Antibody (ensituximab)
Anti-NGF / bNGF Reference Antibody (fasinumab)
Anti-Nucleocapsid Antibody (N-18)
Anti-OSMR Reference Antibody (vixarelimab)
Anti-PCSK9 Reference Antibody (evolocumab)
Anti-LILRB2 / ILT4 / CD85d Reference Antibody (JTX-8064)
Anti-LOXL2 Reference Antibody (simtuzumab)
Anti-Mesothelin Reference Antibody (amatuximab)
Anti-MICB Reference Antibody (U.Washington patent anti-MICB)
Anti-MUC16 Reference Antibody (sofituzumab)
Anti-NCAM1 / CD56 Reference Antibody (lorvotuzumab)
Anti-NT5E / CD73 Reference Antibody (mupadolimab)
Anti-Nucleocapsid Antibody (N-P10)
Anti-PCSK9 Reference Antibody (bococizumab)
Anti-PCSK9 Reference Antibody (lodelcizumab)
Anti-LAG3 / CD223 Reference Antibody (ieramilimab)
Anti-LEPR / CD295 Reference Antibody (mibavademab)
Anti-MAGEA3 Reference Antibody (CT Atlantic patent anti-MAGE-A3)
Anti-MERS Reference Antibody (2E6)
Anti-MSPR / RON / CD136 Reference Antibody (Aveo anti-RON)
Anti-MUC1 Reference Antibody (gatipotuzumab)
Anti-NGF / bNGF Reference Antibody (tanezumab)
Anti-NOTCH3 Reference Antibody (Genentech patent anti-Notch3)
Anti-oxLDL Reference Antibody (orticumab)
Anti-PAR2 Reference Antibody (Regeneron patent anti-PAR-2)
Anti-LAG3 / CD223 Reference Antibody (encelimab)
Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumAb)
Anti-LY75 / CD205 Reference Antibody (MEN1309)
Anti-MICA Reference Antibody (CLN-619)
Anti-MPL / TPOR / CD110 Reference Antibody (TA136)
Anti-MUSK Reference Antibody (Argenx patent anti-MuSK)
Anti-NGF / bNGF Reference Antibody (fulranumab)
Anti-Nogo Receptor / NgR Reference Antibody (Abbott patent anti-NGR)
Anti-Osteopontin Reference Antibody (ASK8007)
Anti-PACAP38 Reference Antibody (Lilly patent anti-PACAP)
Anti-LILRB4 / ILT3 / CD85k Reference Antibody (Merck patent anti-ILT3 complex)
Anti-LRRC15 / LIB Reference Antibody (samrotamab)
Anti-Mesothelin Reference Antibody (anetumab)
Anti-MIF Reference Antibody (imalumab)
Anti-MUC17 Reference Antibody (Forerunner patent anti-Muc 17)
Anti-Nectin-4 Reference Antibody (enfortumab)
Anti-NT5E / CD73 Reference Antibody (oleclumab)
Anti-Nucleocapsid Antibody (N-P11)
Anti-PCSK9 Reference Antibody (Boehringer anti-PCSK9)
Anti-PCSK9 Reference Antibody (Merck patent anti-PCSK9)
Anti-LAG3 / CD223 Reference Antibody (miptenalimab)
Anti-Lewis Y Reference Antibody (MB 311)
Anti-MASP2 Reference Antibody (narsoplimab)
Anti-MERS Reference Antibody (3A1)
Anti-MSPR / RON / CD136 Reference Antibody (narnatumab)
Anti-MUC16 Reference Antibody (abagovomab)
Anti-NKG2A / CD159a Reference Antibody (monalizumab)
Anti-NOTCH3 Reference Antibody (tarextumab)
Anti-PAC1 Reference Antibody (zelminemab)
Anti-PCLA Reference Antibody (U.Penn. patent anti-PCLA)
Anti-LAG3 / CD223 Reference Antibody (favezelimab)
Anti-LAMP1 / CD107a Reference Antibody (SAR428926)
Anti-LYPD3 / C4.4A Reference Antibody (lupartumab)
Anti-Melanotransferrin / CD228 Reference Antibody (SC-005)
Anti-MRC2 / CD280 Reference Antibody (Copenhagen Rigshospitalet patent anti-uPARAP)
Anti-MUC1 Reference Antibody (cantuzumab)
Anti-NGF / bNGF Reference Antibody (MEDI-578)
Anti-NOTCH1 Reference Antibody (brontictuzumab)
Anti-OX2R / CD200R1 Reference Antibody (Janssen patent anti-CD200R1)
Anti-PAR2 Reference Antibody (Amgen patent anti-PAR-2)
Anti-LILRB4 / ILT3 / CD85k Reference Antibody (U.Texas patent anti-LILRB4)
Anti-Ly6E Reference Antibody (RG7841)
Anti-Mesothelin Reference Antibody (BMS-986148)
Anti-MMP9 Reference Antibody (andecaliximab)
Anti-MUC18 / MCAM / CD146 Reference Antibody (imaprelimab)
Anti-NGF / bNGF Reference Antibody (AS2886401-00)
Anti-NT5E / CD73 Reference Antibody (uliledlimab)
Anti-Orai1 Reference Antibody (Amgen patent anti-ORAI1)
Anti-PCSK9 Reference Antibody (ebronucimab)
Anti-PCSK9 Reference Antibody (ongericimab)
Anti-LAG3 / CD223 Reference Antibody (relatlimab)
Anti-LIF Reference Antibody (MSC-1)
Anti-Matriptase Reference Antibody (Oxford Bio patent anti-Matriptase)
Anti-MERS Reference Antibody (D12)
Anti-MUC1 Reference Antibody (AR20.5)
Anti-MUC16 Reference Antibody (oregovomab)
Anti-NKG2D / CD314 Reference Antibody (tesnatilimab)
Anti-NRP1 / VEGF165R / CD304 Reference Antibody (vesencumab)
Anti-Nucleocapsid Antibody (N-9)
Anti-PCSK9 Reference Antibody (alirocumab)
Anti-PCSK9 Reference Antibody (frovocimab)
Anti-LAG3 / CD223 Reference Antibody (fianlimab)
Anti-LAP Reference Antibody (Brigham and Womens anti-LAP)
Anti-MADCAM1 Reference Antibody (ontamalimab)
Anti-MER / MERTK Reference Antibody (RGX-019)
Anti-MRC2 / CD280 Reference Antibody (Quark patent anti-ENDO 180)
Anti-MUC1 Reference Antibody (clivatuzumab)
Anti-NGF / bNGF Reference Antibody (PG110)
Anti-NOTCH1 Reference Antibody (Pfizer patent anti-Notch1)
Anti-oxLDL Reference Antibody (Okayama U. patent anti-oxLDL)
Anti-PAR2 Reference Antibody (PAR650097)
47
48
49
50
51
52
53
54
55
56
57
Copyright 2017 © ChemicalBook. All rights reserved